Pharma Social Media Sites Struggle For Audience Under Shadow Of Potential FDA Action
Executive Summary
Drug makers are using YouTube videos and other social media channels to broadcast their expertise and initiatives; Amgen differentiates its biologic manufacturing from biosimilars, J&J teams up with Huffington Post to tell stories about motherhood, and Pfizer tries to conduct a clinical trial online.
You may also be interested in...
Third-Party Social Media: Firms Should Not Be Selective In Corrections
FDA’s draft guidance on correcting independent third-party misinformation about drugs and devices advises companies to address exaggerated efficacy claims as well as incorrect risk information.
Third-Party Social Media Sites: Firms Should Not Be Selective In Corrections
FDA’s draft guidance on correcting independent third-party misinformation about Rx drugs and devices advises firms to address exaggerated efficacy claims as well as incorrect risk information.
Wikipedia Disease Information Worth Monitoring By Pharma Companies, IMS Says
An analysis of Wikipedia page visits over the last two years shows that rarer diseases had a higher frequency of visits than many more common conditions, IMS Institute for Health Informatics says.